Polarean Imaging

Due to the stop-and-start nature of shows re-opening post-pandemic and an eventual FDA approval, built in 2021, this stunning exhibit FINALLY debuted at ATS 2023 in Washington, DC.
This exhibit features:
  • 40’ long curved double-sided front sign and a sheer image rear sign
  • Custom carpet inlays to mirror the curve of the wall
  • Custom curved LED tile wall in the front and a custom LED wall on the outer side.
  • Custom MRI façade to help tell the story of the Xenon MRI Platform

By researching, developing, and commercializing novel imaging solutions with a non-invasive and radiation-free functional imaging platform, Polarean’s vision is to help address the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarization science and has successfully developed the first and only hyperpolarized MRI contrast agent to be approved in the United States.

Polarean aspires to revolutionize pulmonary medicine by bringing the power and safety of MRI to the respiratory healthcare community in need of new solutions to evaluate lung function, diagnose disease, characterize disease progression, and monitor response to treatment.

Exhibit